Agilon Health (NYSE:AGL) Sets New 12-Month Low After Earnings Miss

Key Points

• Agilon Health's shares fell to a new 52-week low of $0.71 after the company reported a quarterly earnings per share (EPS) of ($0.25), missing analysts' expectations by ($0.14).
• The company's revenues decreased by 5.9% compared to the previous year, coming in at $1.39 billion, below the estimated $1.47 billion.
• Recent analyst ratings for Agilon Health include a price target cut by Wells Fargo to $5.00, while other analysts maintained varying targets, leading to a consensus rating of "Hold".

Agilon Health, Inc. (NYSE:AGL - Get Free Report)'s stock price hit a new 52-week low during trading on Tuesday following a dissappointing earnings announcement. The company traded as low as $0.71 and last traded at $0.89, with a volume of 174932843 shares. The stock had previously closed at $1.82.

The company reported ($0.25) earnings per share for the quarter, missing analysts' consensus estimates of ($0.11) by ($0.14). The business had revenue of $1.39 billion during the quarter, compared to the consensus estimate of $1.47 billion. Agilon Health had a negative return on equity of 66.76% and a negative net margin of 5.35%. Agilon Health's quarterly revenue was down 5.9% compared to the same quarter last year. During the same quarter in the prior year, the business posted ($0.07) earnings per share.

Wall Street Analysts Forecast Growth

A number of equities analysts have issued reports on AGL shares. JMP Securities reiterated a "market perform" rating on shares of Agilon Health in a report on Monday, April 28th. The Goldman Sachs Group boosted their target price on shares of Agilon Health from $2.50 to $5.00 and gave the company a "neutral" rating in a report on Thursday, May 8th. Barclays dropped their target price on shares of Agilon Health from $3.00 to $1.50 and set an "underweight" rating on the stock in a report on Wednesday. TD Cowen boosted their target price on shares of Agilon Health from $3.50 to $6.00 and gave the company a "hold" rating in a report on Tuesday, April 15th. Finally, Benchmark dropped their target price on shares of Agilon Health from $4.00 to $1.50 and set a "buy" rating on the stock in a report on Wednesday. Two investment analysts have rated the stock with a sell rating, eleven have given a hold rating and five have assigned a buy rating to the company's stock. Based on data from MarketBeat, Agilon Health has a consensus rating of "Hold" and a consensus target price of $4.07.

Institutional Investors Weigh In On Agilon Health

Hedge funds have recently added to or reduced their stakes in the stock. Humankind Investments LLC bought a new stake in Agilon Health in the fourth quarter worth $30,000. Raymond James Financial Inc. purchased a new position in shares of Agilon Health in the fourth quarter worth $33,000. Cerity Partners LLC purchased a new position in shares of Agilon Health in the fourth quarter worth $34,000. 111 Capital purchased a new position in shares of Agilon Health in the second quarter worth $36,000. Finally, Nisa Investment Advisors LLC raised its stake in shares of Agilon Health by 244.9% in the first quarter. Nisa Investment Advisors LLC now owns 9,553 shares of the company's stock worth $41,000 after purchasing an additional 6,783 shares during the last quarter.

Agilon Health Price Performance

The company has a 50 day moving average price of $2.10 and a two-hundred day moving average price of $3.17. The stock has a market cap of $339.41 million, a PE ratio of -1.06 and a beta of 0.14.

Agilon Health Company Profile

agilon health, inc. provides healthcare services for seniors through primary care physicians in the communities of the United States. It offers a platform that manages the total healthcare needs of the patients by subscription-like per-member per-month. The company was formerly known as Agilon Health Topco, Inc and changed its name to agilon health, inc.